Speciality Medicines logo

Speciality Medicines

Listed

IPO Timeline

Issue open date

20 Mar 2026

Issue close date

24 Mar 2026

UPI mandate deadline

24 Mar 2026

Allotment finalization

25 Mar 2026

Refund initiation

27 Mar 2026

Share credit

27 Mar 2026

Listing date

30 Mar 2026

Mandate end date

9 Apr 2026

Lock-in end date for anchor investors (50%)

24 Apr 2026

Lock-in end date for anchor investors (remaining)

23 Jun 2026

Key Dates

Open
20 Mar 2026
Close
24 Mar 2026
Listing
30 Mar 2026

Quick Stats

Issue Size:29cr
Lot Size:1000 shares

About the Company

Speciality Medicines Limited sells medicines used to treat serious and long-term health conditions. These include diseases like cancer, immune-related disorders, neurological conditions, and rare illnesses. The company offers a wide range of medicines in different forms such as tablets, capsules, syrups, injections, and inhalers.It runs its business in two main ways. First, it gets medicines manufactured through third-party manufacturers and supplies them to customers, including in international markets. Second, it sources medicines from manufacturers and markets and distributes them to buyers. The company earns its revenue mainly by selling these pharmaceutical products. Overall, its focus is on providing specialised medicines that are used for complex treatments across different therapeutic areas. 

Strengths

  • Focuses on speciality medicines for complex and chronic diseases.
  • Diverse product portfolio across multiple therapeutic areas.
  • A wide range of dosage forms enhances product reach.
  • Dual business model of manufacturing and distribution.
  • Presence in international markets through a distribution network.

Risks

  • Dependence on third-party manufacturers for product supply.
  • High reliance on a few key customers for revenue.
  • Strict quality requirements may lead to order cancellations.
  • Ongoing legal proceedings involving a promoter.
  • Exposure to supply disruptions and price volatility.

Speciality Medicines IPO – Frequently Asked Questions

  • The price band for the Speciality Medicines IPO is set at ₹117 to ₹124 per share.
  • The Speciality Medicines IPO opens on March 20, 2026 and closes on March 24, 2026.
  • The tentative listing date for the Speciality Medicines IPO is March 30, 2026.
  • You can apply for the Speciality Medicines IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Speciality Medicines, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Speciality Medicines IPO is 1000 shares. Investors must apply for at least one lot (i.e., 1000 shares).